Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by DryBoneson Dec 05, 2020 6:09pm
230 Views
Post# 32044765

AW GEE

AW GEEOnly $200 million.  I guess the Tommies won't be taking this private at $2.50 a share.  I thought I'd consider buying in at $1.50.  But they threw in the towel, dang.  Perhaps  satisfied, I guess , with the 1/000 reverse shaft to the little canadian playing the stockmarket.  Maybe they are just raising money to pay lawsuits?  Who knows.  As  they used to say in the X-files,  "the truth is out there somewhere.  Sure as F isn't here in stockhouse.
<< Previous
Bullboard Posts
Next >>